1. Tjokroprawiro A, et al. 2015. Buku Ajar Ilmu Penyakit Dalam Edisi 2. Surabaya: Pusat Penerbitan dan Percetakan Unair.
2. Goundry B, Bell L, Langtree M, Moorthy A. Diagnosis and management of Raynaud’s phenomenon.BMJ. 2012;344:37-42.
3. Hedge A, Sareen K, Raman N. Approach to diagnosis of Raynaud’s disease. PUMRJ. 2019; 2(1)
4. Cooke JP & Marshall JM. Mechanisms of Raynaud’s disease. Vascular Medicine. 2005; 10:293-307.
5. Hansen-Dispenza H & Narayanan SA. Raynaud Phenomenon. Medscape. 2022. https://emedicine.medscape.com/article/331197-overview
6. Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC. ESVM guidelines-the diagnosis and management of Raynaud’s phenomenon. Vasa. 2017;46(6):413-423.
7. Wigley F, Herrick A, Flavahan N. 2015. Raynaud’s Phenomenon. New York:Springer.
8. Gamer R, Kumari F, Lanyon P, Doherty M, Zhang W. Prevalence, risk factors and association of primary Raynaud’s phenomenon: systemic review and meta-analysis of observational studies. BMJ Open. 2015;5:1-9.
9. Musa R, Qurie A. Raynaud Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK499833/
10. Nietert PJ, Shaftman SR, Silver RM, Wolf BJ, Egan BM, Hunt KJ, Smith EA. Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort. Clin Epidemiol. 2015;7:161-168.
11. Pope JE. Raynaud’s phenomenon (primary). BMJ Clin Evid. 2013;2013:1119.